Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Trading Update

13 Nov 2017 07:00

RNS Number : 2382W
Kingspan Group PLC
13 November 2017
 

Kingspan Group Plc

Trading Update

 

13 November 2017

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues a Trading Update, with trading information for the period to 30 September 2017.

Sales in the nine month period to 30 September were €2.69bn, up 19% on the same period in the prior year (+21% pre currency). Sales in the third quarter were up 17% (+20% pre currency). Underlying sales, pre currency and acquisitions, were up 11% in the year to date and were up 13% in the third quarter.

Insulated Panel sales in the first nine months increased by 16% (+18% pre currency), and increased by 13% (+15% pre currency) in the third quarter. Underlying sales were 12% ahead both year to date and in the third quarter, owing significantly to the pass-through of input related inflation. Mainland European sales were solid in most markets and notably positive in France. In the UK we have experienced a sense of near-term indecision around order placement, however our future activity tracker remains modestly ahead of prior year. North America sales were solid overall, and in Latin America we have experienced very encouraging activity since taking a position there in recent months.

Insulation Board sales in the first nine months were up 10% (+13% pre currency) and were up by 16% in quarter three (+19% pre currency). Underlying sales growth was 13% year to date and 19% in the third quarter. Sales growth year on year reflected strong price growth necessitated by raw material inflation. In addition Kooltherm® volume continued to outgrow our other insulation materials, and was particularly positive in the UK, Ireland, Western Europe and the Nordics. The North America and Australasia markets are still in a developmental phase for Kingspan as we are still in the early days of generating demand for high performance insulation in these markets.

 

Light & Air sales both year to date and in the third quarter are strongly ahead reflecting year on year acquisition activity. Underlying sales year to date grew by 4% and by 7% in the third quarter. As we exit 2017 the annualised sales of this division will be in the region of €220m.

Environmental sales in the first nine months were up 12% (+17% pre currency) and were up 11% (+14% pre currency) in the third quarter. A particular highlight was the ongoing growth in rainwater harvesting in Australia. UK and Europe sales were solid overall, and margins continue to progress upwards.

Access Floors sales in the first nine months increased by 2% (+5% pre currency) and were up 4% (+9% pre currency) in the third quarter. UK office activity is softening, as expected, with the US office market remaining relatively flat. Datacentre activity across the division was encouraging as was the continued growth in sales of our broader product portfolio into that segment.

 

Net debt at the end of September 2016 was €479.8m. Net debt at year end is forecast to be in the region of €400m.

 

On the back of significant input inflation in the third quarter, and our associated price inflation, we anticipate this trend to remain through the fourth quarter albeit less pronounced as chemical cost increases reach their peak. In general our end markets are relatively stable, notwithstanding some recent evidence of a slowdown in UK commercial and industrial activity. Separately, the Group's development pipeline is encouraging.

 

Assuming current exchange rates prevail and conscious that much of the seasonally variable fourth quarter remains, we expect to deliver full year trading profit growth of approximately 10% or c. €375m.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKKDBOBDDADD
Date   Source Headline
24th Nov 201410:22 amRNSHolding(s) in Company
18th Nov 20144:49 pmRNSHolding(s) in Company
11th Nov 201412:48 pmRNSAcquisition
10th Nov 20147:00 amRNSInterim Management Statement
6th Nov 20149:35 amRNSHolding(s) in Company
3rd Nov 201411:15 amRNSTotal Voting Rights
3rd Nov 20147:00 amRNSAcquisition update
14th Oct 201410:11 amRNSHolding(s) in Company
2nd Oct 20145:09 pmRNSDirector/PDMR Shareholding
1st Oct 201411:00 amRNSTotal Voting Rights
29th Sep 20143:00 pmRNSHolding(s) in Company
12th Sep 201412:00 pmRNSDirector/PDMR Shareholding
8th Sep 20147:00 amRNSMain Securities Market Notice
2nd Sep 20145:01 pmRNSBlock Listing Application
1st Sep 201410:22 amRNSTotal Voting Rights
28th Aug 20145:59 pmRNSHolding(s) in Company
26th Aug 20147:00 amRNSHalf Yearly Report
18th Aug 20142:30 pmRNSHolding(s) in Company
18th Aug 201410:26 amRNSHolding(s) in Company
18th Aug 20147:00 amRNSAcquisition
30th Jul 20143:42 pmRNSHolding(s) in Company
29th Jul 20143:07 pmRNSHolding(s) in Company
3rd Jul 201412:39 pmRNSHolding(s) in Company
1st Jul 20142:50 pmRNSBlocklisting Interim Review
1st Jul 201410:45 amRNSTotal Voting Rights
23rd Jun 201410:48 amRNSDirector/PDMR Shareholding Replacement
19th Jun 20144:43 pmRNSDirector/PDMR Shareholding
19th Jun 201412:56 pmRNSDirector/PDMR Shareholding
19th Jun 201410:12 amRNSHolding(s) in Company
3rd Jun 20141:07 pmRNSDirector/PDMR Shareholding
3rd Jun 201410:36 amRNSTotal Voting Rights
22nd May 201412:22 pmRNSDirector/PDMR Shareholding
1st May 20143:32 pmRNSDirectorate Change
1st May 201410:39 amRNSAGM Results
1st May 20148:00 amRNSTotal Voting Rights
1st May 20147:00 amRNSInterim Management Statement
10th Apr 20144:39 pmRNSDirector/PDMR Shareholding
3rd Apr 201410:27 amRNSHolding(s) in Company
2nd Apr 20149:59 amRNSTotal Voting Rights
28th Mar 20146:30 pmRNSAnnual Financial Report
28th Mar 20147:01 amRNSSuccessful extension and re-pricing of EUR300m RCF
6th Mar 20144:49 pmRNSDirector/PDMR Shareholding
4th Mar 20144:06 pmRNSDirector/PDMR Shareholding
3rd Mar 201410:28 amRNSTotal Voting Rights
26th Feb 20145:27 pmRNSDirector/PDMR Shareholding
26th Feb 20143:48 pmRNSHolding(s) in Company
25th Feb 201412:52 pmRNSDirector/PDMR Shareholding
24th Feb 20147:00 amRNSFinal Results
24th Feb 20147:00 amRNSMain Securities Market Notice
21st Feb 20143:35 pmRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.